Abstract
The first total synthesis of Sannanine has been accomplished with an overall 30% yield in a concise manner. The key strategies involve Friedländer quinoline synthesis, demethylation, in situ oxidation and amination process.
Graphical Abstract
The first total synthesis of Sannanine has been accomplished with an overall 30% yield in a concise manner. The key strategies involve Friedländer quinoline synthesis, demethylation, in situ oxidation and amination processes.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
1 Introduction
Quinoline-5,8-dione is one of the most important cores, found in many natural products as well as in biologically potent molecules[1] (Figure 1). The potential of quinoline-5,8-dione has been proved in a variety of fields. In general, quinoline-5,8-dione shows the predominant biological activities such as anticancer, antimalarial, anti-inflammatory, and antifungal.[1]\(^{\mathrm{a},}\)[2] In addition, quinolone-5,8-dione has very good tenancy to form complexes with transition metals which result in dramatic changes in biological as well as photo-physical properties of quinoline-5,8-dione. Due to bathochromic shift of the metal complex of the quinolone-5,8-dione, quinoline-5,8-dione core has also revealed its potential in ‘colour formers’.[3] Subsequently quinoline-5,8-dione is also used as a fundamental core in the synthesis of many natural products as well as biological efficient molecules. In short, quinoline-5,8-dione has a vital role in most of the fields such as synthetic, biological, and material chemistry.[4]
Sannanine (1) (Figure 1), an anticancer agent, was isolated from Streptomyces sannanensis in 2009 by Han and co-workers and it was found that sannanine exhibits anticancer activity against the four cancer cell lines, such as BGC823, PANC1, HepG2 and H460 with \(\hbox {IC}_{50}\) values of 6.6, 5.8, 3.1 and \(1.8\,\mu \hbox {M}\), respectively.[5] Due to excellent biological activity of sannanine, there is an urgency for its synthesis. Till date, there is no synthetic report on sannanine natural product. Due to more efficacy of the quinoline-5,8-dione core, the natural product sannanine was chosen as an our target molecule, as a part of ongoing natural product synthesis.
2 Experimental
2.1 General
All the chemicals were used as purchased (Sigma Aldrich & Avra Synthesis P. Ltd., India) for the reaction without any purification. As per standard procedures, all solvents were dried for the reactions. In addition, highly moisture sensitive reactions were performed under nitrogen atmosphere. All the newly synthesized compounds were characterized by NMR in which \(\hbox {CDCl}_{3}\) and DMSO-\(d_{\textit{6}}\) were used as solvents. In \(^{1}\hbox {H}\) NMR, 7.26 ppm and 2.53 ppm peaks were fixed for \(\hbox {CDCl}_{3}\) and DMSO-\(d_{\textit{6}}\) solvents, respectively. All the compounds were further characterized HRMS and IR spectral analysis. For all the newly synthesized by solid compounds, melting points were determined.
2.2 Synthetic procedure for 5,8-dimethoxy-2,3-dimethylquinoline (3) and 2-ethyl-5,8-dimethoxyquinoline (6)
2-Amino-3,6-dimethoxybenzaldehyde (5 g, 0.0275 mol) was taken in EtOH (10 mL). Then, 10% ethanolic KOH (1.1 equiv.) was added to the reaction mixture and stirred for 12 h at \(90\, ^{\circ }\hbox {C}\) under \(\hbox {N}_{2}\) atmosphere. The completion of reaction was monitored by thin layer chromatography (TLC). After completion of reaction, the reaction mixture was poured into water (100 mL) and extracted with EtOAc \((4 \times 50\, \hbox {mL})\). The crude product was purified by column chromatography using hexane/EtOAc solvent mixture. Finally, 5,8-dimethoxy-2,3-dimethylquinoline was obtained as a colourless solid in 62% yield. \(\hbox {R}_{\mathrm{f}} = 0.23\) (20% EtOAc/Hexane); M.p.: \(126\, ^ {\circ }\hbox {C}\); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 3586, 3484, 3004, 2941, 2915, 2815, 2835, 1621, 1609, 1482, 1467, 1454, 1426, \(1404\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \, 8.16\) (s, 1H), 6.77 (d, \(J = 8.4\, \hbox {Hz}\), 1H), 6.60 (d, \(J = 8.4\, \hbox {Hz}\), 1H), 3.96 (s, 3H), 3.86 (s, 3H), 2.68 (s, 3H), 2.38 (s, 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3, }100\, \hbox {MHz}\)): \(\delta \) 158.3, 148.9, 148.2, 138.6, 130.1, 129.8, 120.6, 105.6, 102.8, 55.9, 55.6, 23.8, 19.6; HRMS (ESI): m/z calcd. for \(\hbox {C}_{13}\hbox {H}_{15}\hbox {NO}_{2}\, [\hbox {M + H}]^{+}\): 218.1182, found: 218.1185.
2.2.1 2-Ethyl-5,8-dimethoxyquinoline (6)
Yield: 34%; brown coloured liquid; \(\hbox {R}_{\mathrm{f}} = 0.28\) (20% EtOAc/Hexane); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 3553, 3466, 3010, 2923, 2910, 2715, 2635, 1631, 1619, 1475, 1467, 1434, \(1416,\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \, 8.47\) (d, \(J = 8.6\, \hbox {Hz}\), 1H), 7.36 (d, \(J = 8.6\, \hbox {Hz}\), 1H), 6.91 (d, \(J = 8.5\, \hbox {Hz}\), 1H), 6.70 (d, \(J = 8.5\, \hbox {Hz}\), 1H), 4.03 (s, 3H), 3.94 (s, 3H), 3.08 (q, \(J = 7.5\, \hbox {Hz}\), 2H), 1.40 (t, \(J = 7.3\, \hbox {Hz}\), 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3,}100\, \hbox {MHz}\)): \(\delta \) 163.4, 148.9, 148.6, 139.9, 131.0, 120.1, 119.9, 106.8, 102.7, 55.9, 55.5, 32.3, 14.1; HRMS (ESI): m/z calcd. for \(\hbox {C}_{13}\hbox {H}_{15}\hbox {NO}_{2}\, [\hbox {M + H}]^{+}\): 218.1182, found: 218.1174.
2.3 Synthetic procedure for 2,3-dimethylquinoline-5,8-dione (2)
5,8-Dimethoxy-2,3-dimethylquinoline (2 g, 0.0092 mol) was taken in \(\hbox {CH}_{3}\hbox {CN}\) (15 mL). This was followed by addition of aq. ceric ammonium nitrate (CAN) (0.0229 mol) to the reaction mixture at room temperature and allowed to stir for 1 h. The reaction was monitored by TLC. After completion of reaction, the reaction mixture was poured in water (50 mL) and extracted with EtOAc (\(5 \times 20\, \hbox {mL}\)). The crude product was further used for the next reaction without purification. Yield: 83% as a red coloured solid; \(\hbox {R}_{\mathrm{f}} = 0.23\) (50% EtOAc/Hexane); M.p.: \(102\, ^{\circ }\hbox {C}\); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 1655, 1640, 1461, 1423, 1400, 1390, \(1350\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \, 8.08\) (s, 1H), 7.07 (d, \(J = 10.4\, \hbox {Hz}\), 1H), 6.98 (d, \(J = 10.3\, \hbox {Hz}\), 1H), 2.71 (s, 3H), 2.46 (s, 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3, }100\, \hbox {MHz}\)): \(\delta \) 185.1, 183.6, 164.2, 144.8, 138.8, 137.6, 137.6, 134.4, 127.4, 23.4, 19.7; HRMS (ESI): m/z calcd. for \(\hbox {C}_{11}\hbox {H}_{9}\hbox {NO}_{2}\, [\hbox {M + H}]^{+}\): 188.0712, found: 188.0717.
2.4 General synthetic procedure for the compounds 1 and 8-19
2,3-Dimethylquinoline-5,8-dione (0.0004 mol) was taken in EtOH (2 mL). Subsequently, the amines (1.5 equiv.) were added to the reaction mixture and allowed to stir for 2 h at room temperature. After completion of reaction, the solvent was evaporated under reduced pressure and finally the crude products were purified by column chromatography using hexanes/EtOAc mixtures.
2.4.1 2,3-Dimethyl-6-(methylamino)quinolone-5,8-dione (1)
Yield: 49% (in two steps) as a red colored solid; \(\hbox {R}_{\mathrm{f}} = 0.44\) (EtOAc/Hexane); M.p.: \(198\, ^ {\circ }\hbox {C}\); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 3288, 1683, 1627, 1596, 1550, 1505, 1453, 1414, 1372, 1333, 1290, 1234, \(1200\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 500 MHz): \(\delta \) 7.99 (s, 1H), 5.97 (s, 1H), 5.80 (s, 1H), 2.90 (d, \(J = 4.5\, \hbox {Hz}\), 3H), 2.66 (s, 3H), 2.39 (s, 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3,}125\, \hbox {MHz}\)): \(\delta \) 181.81, 181.80, 164.4, 148.4, 146.8, 135.3, 134.3, 125.4, 101.1, 29.1, 23.4, 19.3; HRMS (ESI): m/z calcd. for \(\hbox {C}_{12}\hbox {H}_{12}\hbox {N}_{2}\hbox {O}_{2}\, [\hbox {M + H}]^{+}\): 217.0978, found: 217.0978.
2.4.2 2,3-Dimethyl-7-(methylamino)quinolone-5,8-dione (7)
Yield: 27% (in two steps) as a red colored solid; \(\hbox {R}_{\mathrm{f}} = 0.16\) (50% EtOAc/Hexane); M.p.: \(192\, ^ {\circ }\hbox {C}\); IR (KBr): \(\upupsilon _{\mathrm{max}} 3331\), 1697, 1596, 1550, 1505, 1453, 1415, 1372, 1333, 1270, 1234, 1200, \(1168\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \) 8.09 (s, 1H), 6.14 (s, 1H), 5.69 (s, 1H), 2.95 (d, \(J = 5.4\, \hbox {Hz}\), 3H), 2.65 (s, 3H), 2.42 (s, 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3, }100\, \hbox {MHz}\)): \(\delta \) 182.2, 180.2, 161.8, 149.1, 144.0, 138.1, 134.4, 129.1, 99.5, 29.2, 23.0, 19.7; HRMS (ESI): m/z calcd. for \(\hbox {C}_{12}\hbox {H}_{12}\hbox {N}_{2}\hbox {O}_{2}\, [\hbox {M + Na}]^{+}\): 239.0795, found: 239.0795.
2.4.3 6-(Benzylamino)-2,3-dimethylquinoline-5,8-dione (8)
Yield: 51% (in two steps) as a red colored solid; \(\hbox {R}_{\mathrm{f}} = 0.16\) (50% EtOAc/Hexane); M.p.: \(180\, ^{\circ }\hbox {C}\); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 3289, 1673, 1624, 1599, 1585, 1552, 1498, 1445, 1381, 1332, 1280, 1228, \(1211\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \) 8.02 (s, 1H), 7.34 (m, 5H), 6.18 (s, 1H), 5.89 (s, 1H), 4.37 (d, \(J = 5.5\, \hbox {Hz}\), 2H), 2.69 (s, 3H), 2.41 (s, 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3,}100\, \hbox {MHz}\)): \(\delta \) 181.9, 181.8, 164.5, 147.1, 146.6, 135.6, 135.4, 134.3, 129.0, 128.2, 127.7, 125.5, 102.2, 46.8, 23.5, 19.4; HRMS (ESI): m/z calcd. for \(\hbox {C}_{18}\hbox {H}_{16}\hbox {N}_{2}\hbox {O}_{2}\, [\hbox {M + H}]^{+}\): 293.1291, found: 293.1288.
2.4.4 7-(Benzylamino)-2,3-dimethylquinoline-5,8-dione (9)
Yield: 24% (in two steps) as a red colored solid; \(\hbox {R}_{\mathrm{f}} = 0.40\) (50% EtOAc/Hexane); M.p.: \(168\, ^ {\circ }\hbox {C}\); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 3245, 1694, 1598, 1550, 1454, 1440, 1415, 1378, 1353, 1335, 1273, 1233, 1202, \(1192\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \) 8.10 (s, 1H), 7.32 (m, 5H), 6.38 (s, 1H), 5.77 (s, 1H), 4.41 (d, \(J = 5.8\, \hbox {Hz}\), 2H), 2.68 (s, 3H), 2.44 (s, 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3,}100\, \hbox {MHz}\)): \(\delta \) 182.4, 180.3, 162.0, 147.9, 144.0, 138.2, 135.6, 134.4, 129.0, 128.2, 127.6, 100.7, 46.9, 23.0, 19.8; HRMS (ESI): m/z calcd. for \(\hbox {C}_{18}\hbox {H}_{16}\hbox {N}_{2}\hbox {O}_{2}\, [\hbox {M + Na}]^{+}\): 315.1109, found: 315.1107.
2.4.5 2,3-Dimethyl-6-(phenethylamino)quinolone-5,8-dione (10)
Yield: 66% (in two steps) as a red colored solid; \(\hbox {R}_{\mathrm{f}} = 0.49\) (EtOAc); M.p.: \(206\,^{\circ }\hbox {C}\); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 3345, 1688, 1614, 1559, 1538, 1460, 1375, 1342, 1292, 1235, 1200, 1156, \(1120\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \) 7.99 (s, 1H), 7.33 (t, \(J = 7.4\, \hbox {Hz}\), 2H), 7.27 (d, J = 7.8 Hz, 1H), 7.22 (d, \(J = 7.2\, \hbox {Hz}\), 2H), 5.92 (s, 1H), 5.89 (s, 1H), 3.46 (q, \(J = 6.9\, \hbox {Hz}\), 2H), 2.98 (t, \(J = 6.9\, \hbox {Hz}\), 2H), 2.69 (s, 3H), 2.40 (s, 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3,}100\, \hbox {MHz}\)): \(\delta \) 181.89, 181.80, 164.4, 147.1, 146.7, 137.6, 135.3, 134.3, 128.8, 128.6, 126.9, 125.4, 101.5, 43.6, 34.2, 23.5, 19.3; HRMS (ESI): m/z calcd. for \(\hbox {C}_{19}\hbox {H}_{18}\hbox {N}_{2}\hbox {O}_{2}\, [\hbox {M + H}]^{+}\): 307.1447, found: 307.1448.
2.4.6 2,3-Dimethyl-7-(phenethylamino)quinolone-5,8-dione (11)
Yield: 30% (in two steps) as a red colored solid; \(\hbox {R}_{\mathrm{f}} = 0.56\) (EtOAc); M.p.: \(148\, ^ {\circ }\hbox {C}\); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 3331, 1698, 1604, 1552, 1508, 1449, 1370, 1332, 1272, 1235, 1202, 1146, \(1106\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \) 8.11 (s, 1H), 7.34 (t, \(J = 7.2\, \hbox {Hz}\), 2H), 7.28 (d, \(J = 3.8\, \hbox {Hz}\), 1H), 7.23 (d, \(J = 7.1\, \hbox {Hz}\), 2H), 6.12 (s, 1H), 5.77 (s, 1H), 3.49 (q, \(J = 6.7\, \hbox {Hz}\), 2H), 3.00 (t, \(J = 7.4\, \hbox {Hz}\), 2H), 2.67 (s, 3H), 2.44 (s, 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3,}100\, \hbox {MHz}\)): \(\delta \) 182.3, 180.2, 161.9, 147.9, 144.0, 138.1, 137.7, 134.4, 129.0, 128.8, 128.6, 126.9, 99.9, 43.9, 34.3, 23.0, 19.7; HRMS (ESI): m/z calcd. for \(\hbox {C}_{19}\hbox {H}_{18}\hbox {N}_{2}\hbox {O}_{2}\, [\hbox {M + Na}]^{+}\): 329.1265, found: 329.1265.
2.4.7 6-((4-Methoxyphenethyl)amino)-2,3-dimethylquinoline-5,8-dione (12)
Yield: 47% (in two steps) as a red colored solid; \(\hbox {R}_{\mathrm{f}} = 0.14\) (50% EtOAc/Hexane); M.p.: \(214\, ^ {\circ }\hbox {C}\); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 3376, 1687, 1605, 1553, 1504, 1467, 1435, 1377, 1342, 1312, 1282, 1240, 1197, \(1183\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \) 7.98 (s, 1H), 7.11 (d, \(J = 7.5\, \hbox {Hz}\), 2H), 6.85 (d, \(J = 7.4\, \hbox {Hz}\), 2H), 5.87 (s, 2H) (Including both -NH proton and -CH (\(7^{\mathrm{th}}\) position) proton), 3.77 (s, 3H), 3.40 (q, \(J = 5.8\, \hbox {Hz}\), 2H), 2.90 (t, \(J = 6.3\, \hbox {Hz}\), 2H), 2.67 (s, 3H), 2.39 (s, 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3,}\) 100 MHz): \(\delta \) 181.9, 181.8, 164.4, 158.5, 147.1, 146.7, 135.3, 134.3, 134.2, 129.6, 125.4, 114.3, 101.4, 55.3, 43.8, 33.4, 23.5, 19.4; HRMS (ESI): m/z calcd. for \(\hbox {C}_{20}\hbox {H}_{20}\hbox {N}_{2}\hbox {O}_{3}\, [\hbox {M + H}]^{+}\): 337.1553, found: 337.1556.
2.4.8 7-((4-Methoxyphenethyl)amino)-2,3-dimethylquinoline-5,8-dione (13)
Yield: 22% (in two steps) as a red colored solid; \(\hbox {R}_{\mathrm{f}} = 0.21\) (50% EtOAc/Hexane); M.p.: \(198\, ^ {\circ }\hbox {C}\); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 3366, 1677, 1615, 1573, 1500, 1477, 1425, 1370, 1345, 1315, 1282, 1251, 1187, \(1180\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \) 8.12 (s, 1H), 7.14 (d, \(J = 8.4\, \hbox {Hz}\), 2H), 6.87 (d, \(J = 8.6\, \hbox {Hz}\), 2H), 6.11(s, 1H), 5.76 (s, 1H), 3.81 (s, 3H), 3.44 (q, \(J = 6.7\, \hbox {Hz}\), 2H), 2.94 (t, \(J = 7.3\, \hbox {Hz}\), 2H), 2.67 (s, 3H), 2.44 (s, 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3,}100 \hbox {MHz}\)): \(\delta \) 182.3, 180.2, 161.9, 158.5, 147.9, 144.0, 138.1, 134.4, 129.6, 129.6, 129.1, 114.3, 99.9, 55.2, 44.1, 33.4, 23.0, 19.7; HRMS (ESI): m/z calcd. for \(\hbox {C}_{20}\hbox {H}_{20}\hbox {N}_{2}\hbox {O}_{3}\, [\hbox {M + H}]^{+}\): 337.1553, found: 337.1554.
2.4.9 6-((2-(1H-Indol-3-yl)ethyl)amino)-2,3-dimethylquinoline-5,8-dione (14)
Yield: 48% (in two steps) as a red colored solid; \(\hbox {R}_{\mathrm{f}} = 0.25\) (50% EtOAc/Hexane); M.p.: \(144\, ^ {\circ }\hbox {C}\); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 3341, 3273, 1685, 1633, 1609, 1588, 1557, 1504, 1462, 1443, 1370, 1329, 1229, 1271, \(1233\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \) 8.17 (s, 1H), 8.12 (s, 1H), 7.63 (d, \(J = 7.9\, \hbox {Hz}\), 1H), 7.41 (d, \(J = 8.1\, \hbox {Hz}\), 1H), 7.24 (t, \(J = 7.7\, \hbox {Hz}\), 1H), 7.17 (t, \(J = 7.5\, \hbox {Hz}\), 1H), 7.10 (s, 1H), 6.18 (s, 1H), 5.78 (s, 1H), 3.55 (q, \(J = 6.0\, \hbox {Hz}\), 1H), 3.18 (t, \(J = 6.9\, \hbox {Hz}\), 1H), 2.67 (s, 3H), 2.44 (s, 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3,}100\, \hbox {MHz}\)): \(\delta \) 182.2, 180.8, 163.8, 148.1, 146.5, 136.7, 135.5, 134.1, 127.5, 125.9, 123.5, 121.4, 118.7, 118.6, 111.8, 111.6, 100.5, 43.1, 23.7, 23.4, 19.0; HRMS (ESI): m/z calcd. for \(\hbox {C}_{21}\hbox {H}_{19}\hbox {N}_{3}\hbox {O}_{2}\, [\hbox {M + H}]^{+}\): 346.1556, found: 346.1557.
2.4.10 7-((2-(1H-Indol-3-yl)ethyl)amino)-2,3-dimethylquinoline-5,8-dione (15)
Yield: 27% (in two steps) as a red colored solid; \(\hbox {R}_{\mathrm{f}} = 0.32\) (50% EtOAc/Hexane); M.p.: \(150\, ^ {\circ }\hbox {C}\); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 3229, 2927, 1682, 1630, 1601, 1584, 1557, 1511, 1460, 1443, 1381, 1337, 1301, 1272, 1244, 1226, \(1175\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \) 8.43 (s, 1H), 8.12 (s, 1H), 7.62 (d, \(J = 7.7\, \hbox {Hz}\), 1H), 7.39 (d, \(J = 7.9\, \hbox {Hz}\), 1H), 7.23 (t, \(J = 6.8\, \hbox {Hz}\), 1H), 7.15 (d, \(J = 7.4\, \hbox {Hz}\), 1H), 7.10 (s, 1H), 6.19 (s, 1H), 5.78 (s, 1H), 3.53 (d, \(J = 6.2\, \hbox {Hz}\), 2H), 3.17 (t, \(J = 6.2\, \hbox {Hz}\), 2H), 2.66 (s, 3H), 2.44 (s, 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3,}100\, \hbox {MHz}\)): \(\delta \) 182.3, 180.2, 161.8, 148.0, 144.0, 138.1, 136.4, 134.4, 129.1, 126.9, 122.3 (2 Ar-C), 119.6, 118.4, 111.8, 111.4, 99.8, 42.7, 24.1, 22.9, 19.7; HRMS (ESI): m/z calcd. for \(\hbox {C}_{21}\hbox {H}_{19}\hbox {N}_{3}\hbox {O}_{2}\, [\hbox {M + H}]^{+}\): 346.1556, found: 346.1552.
2.4.11 6-(Allylamino)-2,3-dimethylquinoline-5,8-dione (16)
Yield: 59% (in two steps) as a red colored viscous liquid; \(\hbox {R}_{\mathrm{f}} = 0.52\) (50% EtOAc/Hexane); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 3281, 1673, 1637, 1566, 1550, 1495, 1451, 1434, 1382, 1334, 1293, 1236, 1203, 1172, \(1102\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \) 7.99 (s, 1H), 5.97 (s, 1H), 5.82 (s, 1H), 5.30 (m, 2H), 3.81 (t, \(J = 5.5\, \hbox {Hz}\), 2H), 2.66 (s, 3H), 2.38 (s, 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3,}100\, \hbox {MHz}\)): \(\delta \) 181.8, 181.8, 164.3, 147.1, 146.6, 135.3, 134.2, 131.4, 125.4, 118.3, 102.0, 44.8, 23.3, 19.2; HRMS (ESI): m/z calcd. for \(\hbox {C}_{14}\hbox {H}_{14}\hbox {N}_{2}\hbox {O}_{2}\, [\hbox {M + Na}]^{+}\): 265.0952, found: 265.0957.
[Note: Due to very low yield, compound 17 was only confirmed by HRMS (ESI): m/z calcd. for \(\hbox {C}_{14}\hbox {H}_{14}\hbox {N}_{2}\hbox {O}_{2} [\hbox {M + H}]^{+}\): 243.1134, found: 243.1134].
2.4.12 2,3-Dimethyl-6-(prop-2-yn-1-ylamino)quinoline-5,8-dione (18)
Yield: 52% (in two steps) as a red colored solid; \(\hbox {R}_{\mathrm{f}} = 0.30\) (50% EtOAc/Hexane); M.p.: \(156\, ^ {\circ }\hbox {C}\); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 3291, 1676, 1647, 1568, 1555, 1505, 1454, 1424, 1380, 1344, 1292, 1246, 1205, 1177, \(1112\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \) 8.00 (s, 1H), 7.77 (d, \(J = 5.5\, \hbox {Hz}\), 1H), 5.79 (s, 1H), 4.03 (t, \(J = 3.0\, \hbox {Hz}\), 2H), 3.26 (s, 1H), 2.55 (s, 3H), 2.37 (s, 3H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3,}100\, \hbox {MHz}\)): \(\delta \) 182.0, 181.1, 163.8, 147.6, 146.1, 135.8, 134.1, 125.9, 102.4, 79.3, 75.0, 31.6, 23.4, 19.1; HRMS (ESI): m/z calcd. for \(\hbox {C}_{14}\hbox {H}_{12}\hbox {N}_{2}\hbox {O}_{2}\, [\hbox {M + Na}]^{+}\): 263.0796, found: 263.0796.
2.4.13 2,3-Dimethyl-7-(prop-2-yn-1-ylamino)quinoline-5,8-dione (19)
Yield: 32% (in two steps) as a red coloured solid; \(\hbox {R}_{\mathrm{f}} = 0.39\) (50% EtOAc/Hexane); M.p.: \(142\, ^ {\circ }\hbox {C}\); IR (KBr): \(\upupsilon _{\mathrm{max}}\) 3261, 1666, 1650, 1575, 1562, 1532, 1467, 1424, 1374, 1354, 1300, 1256, 1235, 1167, 1115, \(1098\, \hbox {cm}^{-1}\); \(^{1}\hbox {H}\) NMR (\(\hbox {CDCl}_{3}\), 400 MHz): \(\delta \) 8.11 (s, 1H), 6.18 (s, 1H), 5.84 (s, 1H), 4.03 (d, \(J = 2.8\, \hbox {Hz}\), 2H), 2.67 (s, 3H), 2.44 (s, 3H), 2.37 (s, 1H); \(^{13}\hbox {C}\) NMR (\(\hbox {CDCl}_{3,}100\, \hbox {MHz}\)): \(\delta \) 182.5, 179.9, 162.2, 147.2, 143.9, 138.2, 134.4, 128.8, 101.5, 77.9, 73.5, 32.3, 23.0, 19.7; HRMS (ESI): m/z calcd. for \(\hbox {C}_{14}\hbox {H}_{12}\hbox {N}_{2}\hbox {O}_{2}\, [\hbox {M + Na}]^{+}\): 263.0796, found: 263.0801.
3 Results and Discussion
The proposed synthetic diagram for sannanine (1) is depicted in Scheme 1. Sannanine could be easily synthesized from quinoline-5,8-dione 2 by Michael addition of methylamine. Similarly, the 5,8-dione 2 could be obtained using demethylation of the quinoline compound 3. At the initial stage, the quinoline compound 3 could be easily obtained by following the standard Friedländer quinoline synthesis.
The synthesis was commenced with the synthesis of starting precursor 4. Using the standard literature procedure, ortho-amino aldehyde compound 4 was synthesized.[6] Having enough starting material 4 in hand, Friedländer quinoline synthesis[7] was carried out to synthesize 2,3-dimethyl-5,8-dimethoxy quinoline 3. The compound 4 was treated with ethyl methyl ketone in the presence of 10% ethanolic KOH solution to afford the quinoline compound 3 in 62% yield and 2-ethyl quinoline 6 as a minor product in 34% yield (overall yield is 96%). Then, the compound 3 was subjected to demethylation and in situ oxidation to arrive at the dimethyl substituted quinoline-5,8-dione 2 which was treated with methylamine to obtain two regio isomers 1 and 7 with 46% and 27% yields (overall yield is 73%) in two steps, respectively. Out of the two regio isomers (1 & 7), 6-N-methylamine substituted quinoline-5,8-dione is our desired natural product 1.
The spectral data of synthesized sannanine resembles with the reported values of 1 under fine shimming NMR. In \(^{1}\hbox {H}\) NMR, the most important characteristic peak is that the methyl peak which should appear as a doublet with respect to NH proton (Table 1). In literature, the two carbonyl peaks for the natural product appeared in 181.78 & 181.75 ppm in \(^{13}\hbox {C}\) NMR. Moreover, the difference between these two carbonyl peaks is 0.03 ppm. Similarly, for the synthesized product 1, the peaks belonging to carbonyl groups appeared in 181.80 & 181.81 ppm and the difference is 0.01 ppm which are closer to reported values of reported \(^{13}\hbox {C}\) NMR. Based on the above data, the synthesized product 1 was confirmed apart from its regio isomer 7. As a result, the sannanine 1 was successfully synthesized in 30% overall yield for the first time using easily affordable starting materials in concise manner.
Subsequent to the synthesis of sannanine 1, the analogues of the natural product 1 were synthesized (Scheme 3). To make a library of sannanine 1, a variety of amines have been chosen as one of the starting materials. The synthesis of analogues of sannanine is outlined in Scheme 3. The quinoline-5,8-dione 2 was treated with different amines to obtained the two different regio isomers in moderate to good yields.
Among all the derivatives, phenyethylamine substituted analogues were obtained in good yields (10 (66%) and 11 (30%)). However, in the case of allylamine, there is an isomer, which belongs to 6-substituted analogue 16, achieved in 59% yield, whereas 7-substituted analogue 17 was found only in trace amount (yield 8%). While considering the biological potent of indole containing compounds, tryptamine core was used in the analogues of 14 and 15. Gratifyingly, all other analogues have reached in moderate to good yields. The major intention of choosing the substitution in the quinoline-5,8-dione core was to develop the method to construct many natural products as well as core structure of the biologically potent molecules using the quinoline-5,8-dione as the main core.
4 Conclusions
In summary, the synthesis of sannanine and its analogues have been accomplished for the first time. The overall yield of the sannanine of 30% was achieved using easily affordable starting materials in a concise manner.
References
(a) Porter T H, Bowman C M and Folkers K 1973 antimetabolites of Coenzyme Q. 16. New Alkylmercaptoquinones Having Antimalarial Curative Activity J. Med. Chem. 16 115; (b) Rao K V, Biemann K and Woodward R B 1963 Studies of the Cycloheptatriene-Norcaradiene Isomerism in Some Novel Steroids J. Am. Chem. Soc. 85 2532; (c) Doyle T W, Balitz D M, Grulich R E, Nettleton D E, Gould S J, Tann C-H and Moews A E 1981 Structure Determination of Lavendamycin – a new Antitumor Antibiotic from Streptomyces Lavendulae Tetrahedron Lett. 22 4595; (d) Boger D L, Yasuda M, Mitscher L A, Drake S D, Kitos S D, Kitos P A and Thompson S C 1987 Streptonigrin and Lavendamycin Partial Structures. Probes for the Minimum, Potent Pharmacophore of Streptonigrin, Lavendamycin, and Synthetic Quinoline-5,8-diones J. Med. Chem. 30 1918
(a) Fryatt T, Pettersson H I, Gardipee W T, Bray K C, Green S J, Salwin A M Z, Beall H D and Moody C J 2004 Novel Quinolinequinone Antitumor Agents: Structure-metabolism Studies with NAD(P)H: Quinone Xidoreductase (NQO1) Bioorg. Med. Chem. 12 1667; (b) Hargreaves R, David C L, Whitesell L and Skibo E B 2003 Design of Quinolinedione-Based Geldanamycin Analogues Bioorg. Med. Chem. Lett. 13 3075; (c) Argreaves R H J, David C L, Whitesell L J, LaBarbera D V, Jamil A, Chapuis J C and Skibo E B 2008 Discovery of Quinolinediones Exhibiting a Heat Shock Response and Angiogenesis Inhibition J. Med. Chem. 51 2492; (d) Behforouz M and Merriman R L 1995 Quinoline-5,8-diones and Methods of Using them USOO5712289A 1; (e) Pearce A N, Chia E W, Berridge M V, Clark G R, Harper J L, Larsen L, Maas E W, Page M J, Perry N B, Webb V L and Copp B R 2007 Anti-inflammatory Thiazine alkaloids Isolated from the New Zeeland Ascidian Aplidium sp.: Inhibitors of the Neutrophil Respiratory Burst in a Model of Gouty Arthritis J. Nat. Prod. 70 936
(a) Machura B, Switlicka A, Wolff M, Tanak D, Musio R, Polanski J and Kruszynki R 2011 Novel Tricarbonyl Rhenium Complexes of 5,8-Quinolinedione Derivatives Synthesis, Spectroscopic Characterisation, X-ray Structure and DFT Calculations J. Organomet. Chem. 696 731; (b) Yoshida K, Noma Y and Ueno Y 1994 Synthesis and Properties of 6-Substituted Quinoline-5,8-Dione Colour Formers J. Chem. Soc. Perkin T. 1 2521
(a) Seradj H, Cai W, Erasga N O, Chenault D V, Knuckles K A, Ragains J R and Behforouz M 2004, Total Synthesis of Novel 6-Substituted Lavendamycin Antitumer Agents Org. Lett. 6 473; (b) Blanco M D M, Avendano C and Menendez J C 1999 Concise synthesis of tetrahydro derivatives of the pyrido[2,3-b]acridine and pyrido[3,2-b]acridine ring systems Tetrahedron 55 12637
Li Y, Zheng D, Li Z, Han L, Cui X, Lang L, Li M, Wang Z, Zhao J and Huang X 2009 Sannanine, A New Cytotoxic Alkaloid From Streptomyces Sannanensis J. Antibiot. 62 647
(a) Fernandez M, Lopez F, Tapia R and Valderrama J A 1989 Studies on the Synthesis of Fused Heterocycles From Ortho-Amino carbonyl Compounds Synth. Commun. 19 3087; (b) Blanco M D M, Avendano C, Cabezas N and Menendez J C 1993 A Friedlander Approach to 3-Substituted 2,5,8-\((1H)\)-Quinolinetrione Heterocycles 36 1387
Hargreaves R H J, David C L, Whitesell L J, LaBarbera D V, Jamil A, Chapuis J C and Skibo E B 2008 Discovery of Quinolinediones Exhibiting a Heat Shock Response and Angiogenesis Inhibition J. Med. Chem. 51 2492
Acknowledgements
BN thanks to the UGC-SRF for fellowship. Both RN and BN acknowledge DST-SERB project number EMR/2016/007015/OC for the funding.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Naveen, B., Nagarajan, R. Total synthesis of sannanine and analogues thereof. J Chem Sci 130, 28 (2018). https://doi.org/10.1007/s12039-018-1431-6
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12039-018-1431-6